Telmisartan and Hydrochlorothiazide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65862-976 -
Package NDC
65862-976-03 -
Application number
ANDA208727 -
SPL ID
b106228d-bd9d-4fa7-b0b8-80d7643c65cf -
SPL set ID
681dfb5c-fc5c-427e-81f6-4b4e934978a2 -
UNII
0J48LPH2TH -
UNII
U5SYW473RQ -
RxCUI
283316 -
RxCUI
283317 -
RxCUI
477130
What the source publishes
- Labeler
- Aurobindo Pharma Limited
- Active ingredients
- Telmisartan and Hydrochlorothiazide
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Telmisartan and Hydrochlorothiazide",
"splId": "b106228d-bd9d-4fa7-b0b8-80d7643c65cf",
"labels": [
{
"setId": "681dfb5c-fc5c-427e-81f6-4b4e934978a2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=681dfb5c-fc5c-427e-81f6-4b4e934978a2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=681dfb5c-fc5c-427e-81f6-4b4e934978a2"
}
],
"routes": [
"ORAL"
],
"labeler": "Aurobindo Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (65862-976-03) / 10 TABLET in 1 BLISTER PACK (65862-976-10)",
"package_ndc": "65862-976-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20161215"
}
],
"productId": "65862-976_b106228d-bd9d-4fa7-b0b8-80d7643c65cf",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "65862-976",
"deaSchedule": null,
"genericName": "Telmisartan and Hydrochlorothiazide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TELMISARTAN",
"strength": "40 mg/1"
},
{
"name": "HYDROCHLOROTHIAZIDE",
"strength": "12.5 mg/1"
}
],
"applicationNumber": "ANDA208727",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20161215",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175359",
"N0000175419",
"M0471776",
"N0000000070",
"N0000175561"
],
"unii": [
"0J48LPH2TH",
"U5SYW473RQ"
],
"rxcui": [
"283316",
"283317",
"477130"
],
"spl_set_id": [
"681dfb5c-fc5c-427e-81f6-4b4e934978a2"
],
"pharm_class_cs": [
"Thiazides [CS]"
],
"pharm_class_pe": [
"Increased Diuresis [PE]"
],
"pharm_class_epc": [
"Thiazide Diuretic [EPC]",
"Angiotensin 2 Receptor Blocker [EPC]"
],
"pharm_class_moa": [
"Angiotensin 2 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Aurobindo Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65862-976_b106228d-bd9d-4fa7-b0b8-80d7643c65cf"